Related Experiment Videos
Solange Peters1, Alfredo Addeo2, Fernanda Gabriela Herrera3
1Cheffe du Service d'oncologie médicale, Département d'oncologie, Centre hospitalier universitaire vaudois et Université de Lausanne, Présidente de l'ESMO 2020-22 (European Society for Medical Oncology), Vice-présidente de la Ligue suisse contre le cancer.
Revue Medicale Suisse
|May 17, 2024
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
PD-(L)1 containing rechallenge strategies in patients with advanced NSCLC previously treated with immunotherapy: A systematic review and meta-analysis across resistance phenotypes.
Cancer treatment reviews·2026
Same author
Definitive Radiotherapy With or Without Chemotherapy After Planned Neoadjuvant Chemoimmunotherapy in Stages II to III NSCLC: An International Multicenter Retrospective Study.
JTO clinical and research reports·2026
Same author
Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Mutant NSCLC Across Treatment Lines: Evidence From the TRACER/HERTras Real-World Cohort.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author
Real-world outcomes of stage III NSCLCs managed by surgery or definitive radiation therapy in the era of immunotherapy.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026